Sugar.fit Raises $11 Million in Series A Funding to Enhance Diabetes Management

The primary focus of Sugar.fit revolves around managing and reversing Type 2 diabetes and pre-diabetes utilising a holistic and data-driven digital health experience.

Bengaluru-based Sugar.fit, a healthtech startup, has secured $11 million in a Series A funding round, with MassMutual Ventures leading the investment.

The round also included contributions from existing investors, such as Cure.fit, Tanglin Venture Partners, and Endiya Partners.

The primary focus of Sugar.fit revolves around managing and reversing Type 2 diabetes and pre-diabetes utilising a holistic and data-driven digital health experience.

The newly acquired funds are earmarked for the expansion of services, the launch of offline facilities, and a substantial thrust into research and development in diabetes management.

Commenting on the funding round, Madan Somasundaram , the cofounder and CEO of Sugar.fit, said, "This investment will further refine our technology and extend our services across India, aiding more individuals in taking charge of their diabetes and enhancing their well-being."

Sugar.fit's current services offer a comprehensive diabetes care program by integrating various devices such as continuous glucose monitors, fitness trackers, and other health diagnostics. These are complemented by accessible connections to diabetes specialists and health coaches.

The startup aims to address a significant health concern in India, where an estimated 100 million individuals battle Type 2 diabetes, with an additional 130 million on the verge of pre-diabetes.

Anvesh Ramineni, the managing partner at MassMutual Ventures, commended the team's approach, stating, "The startup's method combines hardware, software, and analytics to deliver personalised programs and foster lasting behavioural changes for improved health outcomes."

The startup reports positive health outcomes due to its continuous approach to diabetes care, citing an average 2% reduction in HbA1c levels among users after three months.

Established in 2021 by Madan Somasundaram and Shivtosh Kumar, the startup had previously raised $10 million in a seed funding round. And, as per the startup, within 18 months, it gained an eightfold increase in paid subscribers, currently serving over 25,000 users on its platform.

In other related funding updates, Bengaluru-based Leucine Rich Bio recently secured Pre-Series A funding to drive healthcare innovation. This investment intends to foster the development of new healthcare products and fortify the company's research and development capabilities.

Additionally, Gurugram-based healthtech startup Curelo secured $100k in funding from the Indian Institute of Management (IIM) Ahmedabad's CIIE.CO. The funding aims to facilitate seamless booking of at-home blood sample collections, ensuring swift access to blood reports from a preferred lab for patients.